These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9387291)

  • 1. [Anti-tumor activity and immune responses induced by human cancer-associated mucin core peptide].
    Ma Y; Yuan M; Fei L
    Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):419-21. PubMed ID: 9387291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of pancreatic cancer apomucin to mammary and intestinal apomucins.
    Byrd JC; Ho JJ; Lamport DT; Ho SB; Siddiki B; Huang J; Yan PS; Kim YS
    Cancer Res; 1991 Feb; 51(3):1026-33. PubMed ID: 1988113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple forms of intracellular and secreted mucins in a pancreatic cancer cell line.
    Ho JJ; Bi N; Siddiki B; Chung YS; Yuan M; Kim YS
    Cancer Res; 1993 Feb; 53(4):884-90. PubMed ID: 7679052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.
    Kotera Y; Fontenot JD; Pecher G; Metzgar RS; Finn OJ
    Cancer Res; 1994 Jun; 54(11):2856-60. PubMed ID: 7514493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucin synthesis and secretion in various human epithelial cancer cell lines that express the MUC-1 mucin gene.
    Dahiya R; Kwak KS; Byrd JC; Ho S; Yoon WH; Kim YS
    Cancer Res; 1993 Mar; 53(6):1437-43. PubMed ID: 8443822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypeptide core of a human pancreatic tumor mucin antigen.
    Lan MS; Hollingsworth MA; Metzgar RS
    Cancer Res; 1990 May; 50(10):2997-3001. PubMed ID: 2334903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A short synthetic peptide (DTRPAP) induces anti-mucin (MUC-1) antibody, which is reactive with human ovarian and breast cancer cells.
    Avichezer D; Taylor-Papadimitriou J; Arnon R
    Cancer Biochem Biophys; 1998 Jun; 16(1-2):113-28. PubMed ID: 9923971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin.
    Ho JJ; Bi N; Yan PS; Yuan M; Norton KA; Kim YS
    Cancer Res; 1991 Jan; 51(1):372-80. PubMed ID: 1703039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of sialyl-Lewis(a) and sialyl-Lewis(x) with MUC-1 apomucin ina pancreatic cancer cell line.
    Ho JJ; Siddiki B; Kim YS
    Cancer Res; 1995 Aug; 55(16):3659-63. PubMed ID: 7627976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma.
    Goydos JS; Elder E; Whiteside TL; Finn OJ; Lotze MT
    J Surg Res; 1996 Jun; 63(1):298-304. PubMed ID: 8667619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DU-PAN-2, mucin type differentiation antigen of normal and malignant pancreatic ductal cells.
    Metzgar RS; Lan MS; Kim YW; Koriwchak MJ; Mullins TD; Hollingsworth MA
    Prog Clin Biol Res; 1989; 288():53-61. PubMed ID: 2717641
    [No Abstract]   [Full Text] [Related]  

  • 12. Breast cancer associated mucin: a review.
    Segal-Eiras A; Croce MV
    Allergol Immunopathol (Madr); 1997; 25(4):176-81. PubMed ID: 9269507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients.
    Schmitz-Winnenthal FH; Volk C; Z'graggen K; Galindo L; Nummer D; Ziouta Y; Bucur M; Weitz J; Schirrmacher V; Büchler MW; Beckhove P
    Cancer Res; 2005 Nov; 65(21):10079-87. PubMed ID: 16267034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th2-dominated antitumor immunity induced by DNA immunization with the genes coding for a basal core peptide PDTRP and GM-CSF.
    Chu Y; Xia M; Lin Y; Li A; Wang Y; Liu R; Xiong S
    Cancer Gene Ther; 2006 May; 13(5):510-9. PubMed ID: 16341143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucin glycoproteins as tumor markers.
    Feller WF; Henslee JG; Kinders RJ; Manderino GL; Tomita JT; Rittenhouse HG
    Immunol Ser; 1990; 53():631-72. PubMed ID: 2100576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to murine breast cancer cells modified to express MUC-1, a human breast cancer antigen, in transgenic mice tolerant to human MUC-1.
    Carr-Brendel V; Markovic D; Ferrer K; Smith M; Taylor-Papadimitriou J; Cohen EP
    Cancer Res; 2000 May; 60(9):2435-43. PubMed ID: 10811121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of native and deglycosylated colon cancer mucin antigens in normal and malignant epithelial tissues.
    Yan PS; Ho SB; Itzkowitz SH; Byrd JC; Siddiqui B; Kim YS
    Lab Invest; 1990 Nov; 63(5):698-706. PubMed ID: 2232715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells.
    Medina M; Vélez D; Asenjo JA; Egea G; Real FX; Gil J; Subiza JL
    Cancer Res; 1999 Mar; 59(5):1061-70. PubMed ID: 10070964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human B-cell immune response to the polymorphic epithelial mucin.
    Rughetti A; Turchi V; Ghetti CA; Scambia G; Panici PB; Roncucci G; Mancuso S; Frati L; Nuti M
    Cancer Res; 1993 Jun; 53(11):2457-9. PubMed ID: 8495404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human B cell immune response to selected epitopes of the polymorphic epithelial mucin (PEM) in cancer patients.
    Nuti M; Rughetti A; Turchi V; Apollonj-Ghetti C; Scambia G; Frati L
    In Vivo; 1993; 7(6B):645-7. PubMed ID: 7514896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.